WeRide outlined plans to commercialize its L4 AV portfolio in Slovakia during a meeting with His Excellency Mr. Robert Fico Prime Minister of Slovakia.
Peer-nominated award honors leaders who exemplify community impact and a commitment to changing the odds for kids across California.SANTA ANA, Calif., June 9, 2026...
SEATTLE, June 9, 2026 /PRNewswire/ -- Two hundred and fifty nurse practitioners and physician assistants working across multiple clinic locations at Fred Hutchinson Cancer...
Landmark Labor Law to Ensure Fair First Contracts for Workers Heads to U.S. SenateWASHINGTON, June 9, 2026 /PRNewswire/ -- With bipartisan support, the U.S....
EBGLYSS is now the only approved option that offers as few as six maintenance injections per year with no required topicals from the startINDIANAPOLIS,...
- BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham
- Elraglusib will be assessed in combination with dinutuximab beta plus chemotherapy in patients with relapsed and refractory neuroblastoma
- Complete response in neuroblastoma patient achieved in Phase 1 study of elraglusib in refractory pediatric cancers
EU-funded project will help countries build early-warning systems to spot infectious disease threats before clinical cases surge SINGAPORE, June 9, 2026 /PRNewswire/ -- Duke-NUS...